DPC Requests Fiscal Note on South Dakota HB154 340B Expansion
DPC wrote to members of the South Dakota House of Representatives, requesting that a fiscal note be attached to proposed legislation, House Bill 154, which ais to expand the federal 340B program in the state.
DPC Testifies Against HB154 340B Expansion in South Dakota
Today, Domestic Policy Caucus Secretary/Treasurer Kent Kaiser, Ph.D., testified against South Dakota House Bill 154, which would expand the flawed federal 340B drug pricing program in that state.
DPC Appears on WZFG Radio to Discuss HB1473 in North Dakota
On February 27, Domestic Policy Caucus Secretary/Treasurer Kent Kaiser, Ph.D., appeared on WZFG radio's "What's on Your Mind" show to discuss why North Dakota House Bill 1473, which aims to expand the federal 340B drug pricing program, should be opposed.
The Oklahoman op-ed: “This bill was supposed to help OK patients. It fattens hospital wallets instead.”
In the Oklahoma City Oklahoman today, the Domestic Policy Caucus has an op-ed published, asking lawmakers to reject legislation that aims to expand the federal 340B program.
New Domestic Policy Podcast Episode: The Folly of 340B Expansion in North Dakota
In a new Domestic Policy Podcast episode released February 20, Dr. Kent Kaiser and North Dakota Watchdog Network Managing Director Dustin Gawrylow discuss the folly of North Dakota House Bill 1473. The bill aims to expand the federal 340B drug pricing program in the state.
Domestic Policy Caucus Signs on Coalition Letter to Legislators to Stop 340B Expansion in North Dakota
The Domestic Policy Caucus joins American Free Enterprise, AFP North Dakota, and North Dakota Watchdog Network to warn against House Bill 1473, as it would expand the federal 340B Rx drug program and cost North Dakota taxpayers and employers millions of dollars.
DPC Writes to Oklahoma Legislators to Request a "No" Vote on 340B Expansion
Domestic Policy Caucus Secretary/Treasurer Kent Kaiser, Ph.D., today wrote to members of the Oklahoma House of Representatives Civil Judiciary Committee to request a "no" vote on House Bill 2048, which would expand the 340B drug pricing program in the state.
DPC Testifies in Opposition to 340B Expansion in North Dakota
On February 10, Domestic Policy Caucus Secretary/Treasurer Kent Kaiser, Ph.D., testified virtually before the North Dakota State House Committee on Industry, Business, and Labor in opposition to HB1473, which aims to expand the federal 340B drug pricing program in the state.
DPC Appears on Open Range Podcast to Discuss 340B Drug Legislation in North Dakota
Domestic Policy Caucus Secretary/Treasurer Kent Kaiser, Ph.D., recently appeared on the Open Range podcast with host Dustin Gawrylow to discuss the folly of legislation to expand the program in North Dakota.
DPC Urges North Dakota Legislators to Oppose HB1473 Expansion of 340B Program
The Domestic Policy Caucus today wrote to members of the North Dakota House of Representatives Committee on Industry, Business, and Labor to urge rejection of House Bill 1473, which would expand the 340B drug pricing program in the state.